Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases

Siddharth Singh, Herbert C. Heien, Jeph Herrin, Parambir S. Dulai, Lindsey Sangaralingham, Nilay D. Shah, William J. Sandborn

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases'. Together they form a unique fingerprint.

Medicine & Life Sciences